Effect of proton pump inhibitors on voriconazole concentrations in Chinese patients with malignant hematological diseases.

European Journal of Clinical Pharmacology
Qi HuangYueping Jiang

Abstract

To evaluate the influence of three proton pump inhibitors (PPIs) on plasma voriconazole (VOR) concentrations and characterize potential drug-drug interactions (DDIs) between VOR and three PPIs (omeprazole, lansoprazole, and pantoprazole) in Chinese patients with malignant hematological diseases. A simple and reliable 2D-HPLC with internal quality control method was used to ensure accurate concentration measurements. A total of 194 patients in this retrospective study were divided into control (N = 59), omeprazole (OME, N = 57), lansoprazole (LAN, N = 26), and pantoprazole (PAN, N = 52) groups for comparison of plasma VOR trough concentrations. To further validate our retrospective analysis of clinical data, we used molecular docking simulation to analyze the binding affinity of PPIs to the cytochrome P450 2C19 (CYP2C19) and cytochrome P450 3A4 (CYP3A4) enzymes that are integral to the metabolism of PPIs and VOR. Our findings indicated that VOR trough concentrations were significantly higher in patient on PPIs compared with those who were not (P = 0.012). Patients on LAN (P < 0.01) or OME (P < 0.05) had significantly elevated VOR concentrations compared with the control group, whereas those on PAN did not. Although VOR trough co...Continue Reading

References

Apr 16, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·R HylandD A Smith
Nov 18, 2003·British Journal of Clinical Pharmacology·Nolan WoodDon Nichols
Nov 4, 2005·Scandinavian Journal of Gastroenterology·Stefan WöhrerMarkus Raderer
Jun 29, 2006·Clinical Pharmacokinetics·Ursula TheuretzbacherHartmut Derendorf
Dec 22, 2009·Expert Opinion on Drug Safety·Alessandro C PasqualottoRafael Linden
Mar 3, 2012·British Journal of Clinical Pharmacology·Barbara GrünGerd Mikus
Jun 1, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tatyana ZvyagaA David Rodrigues
Apr 27, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yoshiyuki ShirasakaNina Isoherranen
Jan 23, 2015·BMC Health Services Research·Wenjie ZengBrian Godman
May 31, 2015·International Journal of Clinical Pharmacy·Prerna K ChawlaTester F Ashavaid
Nov 7, 2015·Mediterranean Journal of Hematology and Infectious Diseases·Giuseppe Leone, Eligio Pizzigallo
Feb 11, 2016·Drug Metabolism and Pharmacokinetics·Sumonrat ChuwongwattanaChonlaphat Sukasem
Feb 16, 2016·Expert Opinion on Drug Metabolism & Toxicology·Edoardo SpinaJose de Leon
Jun 25, 2016·Journal of Clinical Laboratory Analysis·Santirat PrommasChonlaphat Sukasem
Feb 6, 2017·International Journal of Antimicrobial Agents·Fang QiShasha Liao
Nov 17, 2017·Blood·Gregory A Abel, Heidi D Klepin
Sep 15, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Miao YanHoan Linh Banh
Jun 20, 2019·Drug Metabolism Reviews·Josefine SchulzCharlotte Kloft

❮ Previous
Next ❯

Software Mentioned

Molecular Operating Environment ( MOE
SPSS Statistics
Dock

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.